Skip to main content
. 2022 Apr 23;25(4):827–836. doi: 10.1007/s10120-022-01296-8

Table 1.

Demographic and clinical characteristics of the patients

N = 38
Age (years, mean ± SD) 60.5 ± 9.5
Sex(M/F) 27/11
Body mass index (kg/m2, mean ± SD) 22.6 ± 3.2
ECOG [n (%)]
 0 15(39.5)
 1 10(26.3)
 2 13(34.2)
Previous abdominal surgery [n (%)] 4(10.5)
Comorbidity [n (%)]
  Diabetes 5(13.2)
  Hypertension 7(18.4)
  Respiratory 12(31.6)
  Cardiovascular 7(18.4)
Tumor complications [n (%)]
  Bleeding 5(13.2)
  Obstruction 4(10.5)
 Serum albumin (g/L, mean ± SD) 37.4 ± 3.8
 Total protein (g/L, mean ± SD) 62.9 ± 6.3
 Hemoglobin (g/L, mean ± SD) 116.6 ± 23.0
 Neoadjuvant therapy [n (%)] 12(31.6)
 Invaded esophagus [n (%)] 21(55.3)
cT category [n (%)]
 T1 4(10.5)
 T2 9(23.7)
 T3 11(28.9)
 T4 14(36.8)
cT category [n (%)]
 N0 13(34.2)
 N1 10(26.3)
 N2 7(18.4)
 N3 8(21.1)
cM category [n (%)]
 M0 37(97.4)
 M1 1(2.6)